Materials and methods
=====================

Patients
--------

Twenty-six cases of B-cell non-Hodgkin lymphoma diagnosed by hematopathologists from Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, were enrolled in this study. The diagnosis of B-cell non-Hodgkin lymphoma followed the WHO classification 2008 by using morphological and immunophenotypical features. This study was approved by the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University.

DNA extraction
--------------

Serial 10 μm thick sections were obtained with a standard microtome and disposable blades from paraffin embedded lymph nodes. In brief, waxes were extracted with xylene followed by centrifugation at 6000 g for 10 minutes. After this initial step, pellets were resuspended in absolute ethanol for 5 minutes and centrifuged. Paraffin-free tissue was dried with heating box for 15 minutes at 37°C and subjected to the DNA extraction procedures using QIAamp DNA mini kit (Qiagen). The concentration of DNA was measured with Smartspect (BIO-RAD, USA).

PCR primers and thermalcycler program
-------------------------------------

PCR primers sequences for IgH variable gene framework region 3 (FR3) plus joining region (JH) consensus primers were designed followed BIOMED-2 \[[@B14]\]. These primers were designed to target conserved DNA sequences surrounding the unique hypervariable anigen-binding complementarity determining region 3 (CDR3). To amplify the IgH variable region in Thermalcycler (BIO-RAD, USA), genomic DNA at 800-1000 ng. was added up to a final reaction 50 μl. After the initial \"hot start\" using Faststart (Roche Diagnostic) at 95°C for 7 minutes, PCR cycle program included: denaturing at 95°C for 45 seconds, followed by annealing at 60°C for 45 seconds, and extension at 72°C for 90 seconds. The program was repeated for 34 cycles. A final extension was performed at 72°C for 10 minutes.

Heteroduplex analysis
---------------------

For heteroduplex analysis, the PCR products 20 μl were denatured at 95°C for 5 minutes, and then rapid random renaturation at 4°C for 1 hour. Heteroduplex were detected by polyacrylamide gel electrophoresis (PAGE) on an 6% non-denaturing acrylamide gel (16 × 16 × 0.1 cm) using SE600 Ruby (Amersham Bioscience, USA) at room temperature for 210 minutes at 110 Volts. The gel was then stained with 0.5 μg/ml ethidium bromide and photographed under ultraviolet light using ChemiDoc™XRS System (BIO-RAD, USA). PCR and heteroduplex analysis were performed in duplicate.

LightCycler PCR and High Resolution Melting curve analysis (HRM)
----------------------------------------------------------------

The PCR product of IgH variable region 3 was further amplified in the LightCycler System 480 (Roche Diagnostic). The reaction mixture for each well contained high resolution melting master 10 μl, 5 pmol/μl of IgH (FR3) primer 2 μl, 25 mM of MgCl~2~2.4 μl, dH~2~O PCR grade 4.6 μl, and diluted 1:100 PCR product 1 μl, was added up to a final volume of 20 μl. After the initial \"hot start\", PCR cycle parameters were held at pre-incubator 95°C for 10 minutes, and amplification program was 95°C 10 second, 55°C 15 seconds, and 72°C 15 seconds. High resolution melting program was 95°C 1 minute, 55°C 1 minute, 70°C 1 second. After the 30 PCR amplification cycles, the LightCycler System DNA melting curve was analysed by LightCycler 480 software. All samples were performed in duplicate.

Fluorescent fragment analysis (GeneScan)
----------------------------------------

For GeneScan analysis, the PCR product was carried out using the conditions mentioned above with fluorescence labeled primers. The sequences of fluorescence labeled IgH primers were as follows:

HVF3-3FL 5\'-TCTGCAAATGAACAGCCTGAGAGCC-3\' Dye-label 5\' VIC,

HVF4-3FL 5\'-GAGCTCTGTGACCGCCGCGGACACG-3\' Dye-label 5\' VIC,

HVF5-3FL 5\'-CAGCACCGCCTACCTGCAGTGGAGC-3\' Dye-label 5\' NED,

HVF6-3FL 5\'-GTTCTCCCTGCAGCTGAACTCTGTG-3\' Dye-label 5\' NED,

HVF7-3FL 5\'-CAGCACGGCATATCTGCAGATCAG-3\' Dye-label 5\' PET,

HDF1-3FL 5\'-TGGAGCTGAGCAGCCTGAGATCTGA-3\' Dye-label 5\' 6FAM, and HVF2-3FL 5\'-CAATGACCAACATGGACCCTGTGGA-3\' Dye-label 5\' 6FAM. The amplified fragments were analyzed by ABI 3130 Genetic Analyzer (Applied Bioscience, USA) according to the manufacturer\'s protocol. In brief, each sample contained 1 μl of the PCR product mixed with 10.7 μl of Hi-Di formamide and 0.3 μl of 600 LIZ^®^size standard (Applied bioscience, USA). Samples were denatured at 95°C for 5 minutes and immediately chilled on ice for 2 minutes. The gel used for capillary electrophoresis was POP-4 polymer solution (Applied Bioscience, USA). Results were visualized using the ABI GeneMapper v 3.2 software (Applied Bioscience, USA). The expected size varied from 100-170 bp.

Results
=======

Patients characteristics
------------------------

Age of the patients in this study ranged from 13 to 79 years. As shown in Table [1](#T1){ref-type="table"}, of 26 patients enrolled in this study, 2 patients were diagnosed as Burkitt lymphoma (BL), 4 cases were extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma, 3 cases were follicular lymphoma (FL), 2 cases were nodal marginal zone lymphoma, and the other 15 cases were diffuse large B cell lymphoma (DLBCL). From previous report, the 5 most common types of B-cell non Hodgkin lymphoma in Thailand are DLBCL, FL, MALT lymphoma, BL, and small lymphocytic lymphoma (SLL)\[[@B2]\]. Therefore, this finding is in accordance with the distribution that was observed before. Percentage of lymphoma involvement within each specimen was demonstrated in the Table [1](#T1){ref-type="table"}.

###### 

Summary of cases analyzed by PAGE, GensScan and LightCycler.

  Patient   Age/Sex   Tissues                      Diagnosis                         GeneScan              HRM                           \% tumor/B cell\*
  --------- --------- ---------------------------- --------------------------------- --------------------- ----------------------------- -------------------
  1         58/F      Thyroid gland                Diffuse large B cell              Monoclonal H = 8818   Monoclonal Tm = 84.83         90
                                                                                                                                         
  2         46/M      Lymph node                   Diffuse large B cell              Monoclonal H = 8575   Monoclonal Tm = 85.18         95
                                                                                                                                         
  3         51/F      Soft tissue, submandibular   Diffuse large B cell              Monoclonal H = 8814   Polyclonal Tm = 83.42/86.85   95
                                                                                                                                         
  4         77/F      Lymph node                   Diffuse large B cell              Monoclonal H = 7831   Monoclonal Tm = 88.33         90
                                                                                                                                         
  5         49/M      Stomach                      Diffuse large B cell              Monoclonal H = 9008   Monoclonal Tm = 86.04         90
                                                                                                                                         
  6         63/F      Lymph node                   Diffuse large B cell              Monoclonal H = 7759   Polyclonal Tm = 83.26/88.62   75
                                                                                                                                         
  7         68/M      Lymph node                   Diffuse large B cell              Monoclonal H = 8405   Monoclonal Tm = 85.59         95
                                                                                                                                         
  8         42/M      Lymph node                   Diffuse large B cell              Monoclonal H = 6731   Monoclonal Tm = 86.06         90
                                                                                                                                         
  9         68/F      Skin                         Diffuse large B cell              Monoclonal H = 1599   Monoclonal Tm = 85.01         85
                                                                                                                                         
  10        58/M      Skin                         Diffuse large B cell              Monoclonal H = 8060   Monoclonal Tm = 86.36         95
                                                                                                                                         
  11        68/F      Lymph node                   Diffuse large B cell              Monoclonal H = 8005   Monoclonal Tm = 87.24         90
                                                                                                                                         
  12        35/F      Tonsil                       Follicular lymphoma               Monoclonal H = 8738   Monoclonal Tm = 88.85         90
                                                                                                                                         
  13        70/F      Lacrimal gland               Extranodal marginal zone B cell   Monoclonal H = 8122   Monoclonal Tm = 80.62         95
                                                                                                                                         
  14        61/M      Lymph node                   Follicular lymphoma               Monoclonal H = 6887   Polyclonal Tm = 84.00/87.01   75
                                                                                                                                         
  15        67/F      Lymph node                   Marginal zone B cell              Monoclonal H = 7862   Monoclonal Tm = 86.10         80
                                                                                                                                         
  16        72/M      Tonsil                       Extranodal marginal zone B cell   Monoclonal H = 7004   Monoclonal Tm = 86.15         95
                                                                                                                                         
  17        13/M      omentum                      Burkitt lymphoma                  Monoclonal H = 7936   Monoclonal TM = 86.48         99
                                                                                                                                         
  18        67/F      Soft tissue, cheek           Extranodal marginal zone B cell   Monoclonal H = 8186   Monoclonal Tm = 86.34         95
                                                                                                                                         
  19        60/F      Lymph node                   Diffuse large B cell              Monoclonal H = 7805   Monoclonal Tm = 86.8          99
                                                                                                                                         
  20        79/F      Lymph node                   Marginal zone B cell lymphoma     Monoclonal H = 9120   Monoclonal Tm = 87.29         90
                                                                                                                                         
  21        75/M      Thyroid gland                Extranodal marginal zone B cell   Monoclonal H = 8418   Monoclonal Tm = 87.37         90
                                                                                                                                         
  22        73/F      Soft tissue, neck            Diffuse large B cell              Monoclonal H = 7921   Monoclonal Tm = 85.59         95
                                                                                                                                         
  23        55/M      Lymph node                   Burkitt lymphoma                  Monoclonal H = 8423   Monoclonal Tm = 86.03         99
                                                                                                                                         
  24        72/F      Nasal cavity                 Diffuse large B cell              Monoclonal H = 8974   Monoclonal Tm = 85.55         98
                                                                                                                                         
  25        N/M       Lymph node                   Diffuse large B cell              Monoclonal H = 7742   Monoclonal Tm = 88.44         95
                                                                                                                                         
  26        63/F      Lymph node                   Follicular lymphoma               Monoclonal H = 8977   Monoclonal Tm = 87.14         90

H = Height of peak in GeneScan, N = no record

(\* % tumor/B cell means the percentage of tumor cells when the total B cell population are concerned.)

High Resolution Melting curve analysis and lower limit for detecting monoclonal IgH gene rearrangement
------------------------------------------------------------------------------------------------------

The optimal number of PCR cycles was evaluated using monoclonal sample and polyclonal sample from positive lymph node and tonsil, respectively. Based on previous report, 30 cycles of LightCycler PCR showed the Tm with peak height at least twice as high, and less than one half as wide as a polyclonal tonsil sample. Therefore, the number of PCR at 30 cycles was used to investigate in this study \[[@B15]\].

To evaluate the minimum detectable percentage of IgH monoclonal DNA with melting curve analysis, serial dilutions of IgH tube C monoclone with polyclone at various percentages of 50%, 25%, 12.5%, 6.25%, 3.125%, 1.56%, and 0.78% were performed. After 30 cycles in LightCycler, Tm at a percentage equal 0.78% was still detected as monoclonal group by melting curve analysis as shown in Figure [1](#F1){ref-type="fig"}. For PAGE, one discrete band at specific size could be detected at concentration 3.125% whereas a distinct peak in GeneScan was clearly demonstrated at concentration as low as 0.78% as shown in Figure [2](#F2){ref-type="fig"}, Figure [3](#F3){ref-type="fig"} and Figure [4](#F4){ref-type="fig"}.

![**Detection limit of LightCycler System using melting curve analysis**. DNA of positive sample was diluted with tonsil DNA into 50%, 25%, 12.5%, 6.25%, 3.125%, 1.56%, and 0.78%. At the percentage equal to 0.78, Tm was still detected as monoclone.](1746-1596-5-31-1){#F1}

![**Minimal detection of polyacrylamide gel electrophoresis analysis and ethidium bromide staining of monoclonal IgH gene rearrangement**. The distinct band consistent with monoclonal IgH gene rearrangement could be detected at concentration as low as 3.125%. Lane 1 = GeneRuler 50 bp DNA ladder marker, Lane 2 = positive control, Lane 3 = negative control, Lane 4-10 = serial dilutions 50%, 25%, 12.5%, 6.25%, 3.125%, 1.56%, and 0.78%, respectively.](1746-1596-5-31-2){#F2}

![**Detection of minimal dilution for IgH monoclonality by GeneScan**. The one prominent peak could be detected at concentration as low as 0.78%.](1746-1596-5-31-3){#F3}

![**Detection of minimal dilution for IgH monoclonality by GeneScan**. The one prominent peak could be detected at concentration as low as 0.78%.](1746-1596-5-31-4){#F4}

Comparison of PAGE and GeneScan
-------------------------------

All 26 IgH monoclonal samples showed a sharp band on ethidium bromide stained acrylamide gel with 100-170 bp as demonstrated in Figure [5](#F5){ref-type="fig"}. In GeneScan, all DNA monoclonal samples showed products of IgH which were characterized by 1 or 2 dominant peaks in the GeneScan profile, indicating the presence of B cell clonal proliferation as shown in Figure [6](#F6){ref-type="fig"}. As a result, all 26 samples in this study were confirmed to be monoclonality by GeneScan analysis.

![**IgH gene rearrangement showing the distinct band at 100-170 bp on ethidium bromide stained acrylamide gel**. (arrow) M = GeneRuler 50 bp DNA Ladder Marker (Fermentas), PT = Positive control, NT = Negative control, 1-5 = Patients samples.](1746-1596-5-31-5){#F5}

![**GeneScan analysis of IgH monoclonal sample revealed 1 dominant peak in the profile showing the monoclonal pattern**.](1746-1596-5-31-6){#F6}

Comparison of GeneScan and High Resolution Melting curve analysis
-----------------------------------------------------------------

Comparing GeneScan versus High Resolution Melting curve analysis was performed. In the melting curve analysis by HRM, 23 samples demonstrated a high and narrow DNA melting curve that was greater twice the peak height but less than one half the width, when compared with the polyclonal sample as shown in Figure [7](#F7){ref-type="fig"}. Notably, 3 samples showed polyclonal pattern in melting curve analysis.

![**Demonstrated melting curve analysis in IgH malignant lymphoma using LightCycler System**. (arrow) 1 = positive monoclone, 2 = negative polyclone, 3 = patient sample (monoclone), 4 = patient sample (monoclone), 5 = patient sample (monoclone), 6 = patient sample (polyclone).](1746-1596-5-31-7){#F7}

Discussion
==========

Immunoglobulin heavy chain gene rearrangement has been widely used for diagnosis of B cell monoclonality \[[@B16]\]. At present, detection of monoclonal B cell population is based on heteroduplex including fluorescent PCR with GeneScan analysis. Recently, melting curve analysis (Tm) of duplex DNA has been applied to distinquish the monoclonal from polyclonal population. In this study, three techniques: thermocycler PCR followed by heteroduplex and PAGE, GeneScan analysis and LightCycler PCR with HRM, were investigated in terms of detecting monoclonal immunoglobulin heavy chain variable gene framework region 3 (FR3).

From melting temperature of duplex DNA, 3 samples accounting for 11.5% revealed false negative by expressing polyclonality when compared with GeneScan. No false positive was detected in our series. From a previous report, using PCR-MCA (LightCycler Technology with high-speed amplification, and Idaho-Technology with rapid and high-resolution melting curve analysis -MCA) showed high sensitivity and specificity at 89.2% and 100% respectively \[[@B17]\]. Another study of 10 gastric MALT lymphomas using melting curve analysis with SYBR Green I showed similar sensitivity and specificity at 95.2% and 100%, respectively \[[@B18]\]. This investigation also demonstrated high sensitivity as compared to other reports. The detection of the minimum percentage of monoclonality by HRM in our series was at 0.78% dilution which was higher than previous report \[[@B18]\]. 88.5% sensitivity and 100% specificity were revealed in HRM indicating that a positive result in this method is specific for IgH monoclonality, whereas sensitivity and specificity of PAGE and GeneScan were considered as 100%.

LightCycler technology has been used in many areas of clinical testing because of its rapid turn around time and accuracy. High Resolution Melting curve analysis, which is faster, simpler and less expensive, was developed as the latest method for product analysis in molecular diagnostics \[[@B19],[@B20]\]. As compared all three methods concerning quality and accuracy, GeneScan with specific fluorescence labeled primers and HRM could detect the minimum level as low as 0.78%. However, GeneScan has the highest cost which is approximately 3 times higher when compared with PAGE, and about 2 times when compared with HRM. In conclusion, based on our study, High Resolution Melting curve analysis in LightCycler System still has a potential role for clinically demonstrating monoclonal IgH.
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